Leber Congenital Amaurosis 5-Like (LCA5L) Peptid
LCA5L
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle LCA5L Produkte
- LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- GSEEPLQSKE SHPLPPSQAS TSHAFGDSKV TVVNSIKPSS PTEGKRKIII
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of C21 orf13 antibody,
Alternative Names: C21ORF13 control peptide, C21ORF13 antibody Blocking Peptide, Anti-C21ORF13 Blocking Peptide, MGC33295 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
- Synonyme
- C21orf13 Peptide, 4921526F01Rik Peptide, Lcca5l Peptide, Leber congenital amaurosis 5-like Peptide, LCA5L, lebercilin like Peptide, LCA5L Peptide, Lca5l Peptide
- Hintergrund
- The function of the C21orf13 protein has not been widely studied, and is yet to be fully elucidated.
- Molekulargewicht
- 76 kDa
-
Sie sind hier:
